In conjunction with PNPLA3, TM6SF2, or MBOAT7 variants, the HSD17B13 rs72613567 variant has been used to improve the accuracy for predicting NASH severity and advanced fibrosis [83]. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatohepatitis.